Institutions, medical colleges, District Full Stack and the Product promotion team will collaboratively generate ideas. The advantage of this ecosystem is that it ensures the creation of solutions that address real market needs. By working together, these stake holders will generate impactful, relevant, and high-quality innovations that truly matter which is required by biomedical market.

At mPragati, ideas are transformed into functional prototypes through access to advanced machinery, material science expertise, and design support. The medical colleges provide crucial feedback to validate the prototype’s usability and clinical relevance, while the product promotion team evaluates its market readiness and commercial potential.

Partner incubators can also develop prototypes that seamlessly enter this validation and feedback loop  ensuring every innovation evolves through a structured pathway from concept to market-fit solution.

After rigorous evaluation and feedback from clinicians, mPragati refines the prototype into a finished, functional product. The network of medical colleges and the product promotion team then review and validate it to ensure clinical reliability and market readiness.

Clinicians and doctors from these network medical colleges will then become the first set of users and adopters once the product enters the market, helping generate early validation and trust.

Partner incubators can also bring their finished products into this ecosystem to get them evaluated and validated, ensuring every innovation aligns with real-world healthcare needs.

The finished product will also undergo regulatory approvals with the support and guidance of mPragati, ensuring full compliance with global standards before reaching the market.

After achieving all required regulatory approvals, the finished product will be deployed to partner district centers, where Primary Health Centres (PHCs) and Community Health Centres (CHCs) will evaluate its performance on larger population groups. These real-world trials will generate valuable data and insights, ensuring the product’s effectiveness, safety, and scalability before nationwide rollout.

This stage addresses one of the biggest bottlenecks faced by biomedical startups in India which is market access and adoption. Under this step, BFI Innovation Full Stack, based on the startup’s interest, can transfer the product to the Product Promotion Team, which will drive its go-to-market (GTM) strategy. The team will promote the innovation among doctors, hospital purchase departments, and ensure inclusion in government tenders. They will also facilitate listing on the GeM portal, generate purchase codes in private and corporate hospitals, and support regulatory and institutional approvals. The goal is to ensure that the product not only reaches the market but also generates sales and impact from day one.